spacer
spacer
Go to PDB code: 
protein Protein-protein interface(s) links
Cytokine/cytokine receptor PDB id
2pjy
Jmol
Contents
Protein chains
112 a.a. *
108 a.a. *
79 a.a. *
Waters ×9
* Residue conservation analysis
PDB id:
2pjy
Name: Cytokine/cytokine receptor
Title: Structural basis for cooperative assembly of the tgf-beta si complex
Structure: Transforming growth factor beta-3. Chain: a. Synonym: tgf-beta-3. Engineered: yes. Tgf-beta receptor type-2. Chain: b. Fragment: extracellular domain. Synonym: tgf-beta receptor type ii, tgfr-2, tgf-beta type i receptor, transforming growth factor-beta receptor type ii,
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: tgfb3. Expressed in: escherichia coli. Expression_system_taxid: 562. Gene: tgfbr2. Gene: tgfbr1. Expression_system_taxid: 562
Resolution:
3.00Å     R-factor:   0.244     R-free:   0.297
Authors: J.Groppe,C.Zubieta
Key ref:
J.Groppe et al. (2008). Cooperative assembly of tgf-Beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. Mol Cell, 29, 157-168. PubMed id: 18243111 DOI: 10.1016/j.molcel.2007.11.039
Date:
16-Apr-07     Release date:   05-Feb-08    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P10600  (TGFB3_HUMAN) -  Transforming growth factor beta-3
Seq:
Struc:
412 a.a.
112 a.a.
Protein chain
Pfam   ArchSchema ?
P37173  (TGFR2_HUMAN) -  TGF-beta receptor type-2
Seq:
Struc:
 
Seq:
Struc:
567 a.a.
108 a.a.*
Protein chain
Pfam   ArchSchema ?
P36897  (TGFR1_HUMAN) -  TGF-beta receptor type-1
Seq:
Struc:
503 a.a.
79 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 2 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class: Chains B, C: E.C.2.7.11.30  - Receptor protein serine/threonine kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: ATP + [receptor-protein] = ADP + [receptor-protein] phosphate
ATP
+ [receptor-protein]
= ADP
+ [receptor-protein] phosphate
Molecule diagrams generated from .mol files obtained from the KEGG ftp site
 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     membrane   3 terms 
  Biological process     cell growth   3 terms 
  Biochemical function     receptor activity     9 terms  

 

 
    Added reference    
 
 
DOI no: 10.1016/j.molcel.2007.11.039 Mol Cell 29:157-168 (2008)
PubMed id: 18243111  
 
 
Cooperative assembly of tgf-Beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding.
J.Groppe, C.S.Hinck, P.Samavarchi-Tehrani, C.Zubieta, J.P.Schuermann, A.B.Taylor, P.M.Schwarz, J.L.Wrana, A.P.Hinck.
 
  ABSTRACT  
 
Dimeric ligands of the transforming growth factor-beta (TGF-beta) superfamily signal across cell membranes in a distinctive manner by assembling heterotetrameric complexes of structurally related serine/threonine-kinase receptor pairs. Unlike complexes of the bone morphogenetic protein (BMP) branch that apparently form due to avidity from membrane localization, TGF-beta complexes assemble cooperatively through recruitment of the low-affinity (type I) receptor by the ligand-bound high-affinity (type II) pair. Here we report the crystal structure of TGF-beta3 in complex with the extracellular domains of both pairs of receptors, revealing that the type I docks and becomes tethered via unique extensions at a composite ligand-type II interface. Disrupting the receptor-receptor interactions conferred by these extensions abolishes assembly of the signaling complex and signal transduction (Smad activation). Although structurally similar, BMP and TGF-beta receptors bind in dramatically different modes, mediating graded and switch-like assembly mechanisms that may have coevolved with branch-specific groups of cytoplasmic effectors.
 
  Selected figure(s)  
 
Figure 4.
Figure 4. TβRI Binds in a Distinct Mode at a Composite Interface
(A) Superposition of TGF-β3[A] onto BMP-2[A] (gold) in the BMP-2:BMPRIA binary complex. The surface of BMPRIA is represented in gray (TGF-β3[B], BMP-2[B] not depicted for simplicity).
(B) Superposition of the BMP binary and TGF-β ternary complexes. TβRI is rotated vert, similar 45° around the long axis of the ligand relative to BMPRIA. TGF-β3[A] and TGF-β3[B] are shown as red and blue surfaces, respectively (TβRII and BMP-2 not depicted).
(C) TGF-β3[A] and TβRI are separated by a wide solvent-filled channel. Molecular surfaces are depicted over the ribbons of TGF-β3[A] and TβRI (yellow-gold).
(D) Prehelix extension of TβRI binds long finger of ligand monomer. Prehelix extension highlighted in red, and ligand monomers are colored and oriented as in the figure above (TβRII not depicted).
(E) TβRI Arg58-TβRII Asp118 ion pair at the composite interface. TβRII is shown as ribbon in green, and ligand monomers and TβRI are as above.
(F) TβRII N-terminal extension tethers TβRI to the composite TGFβ3-TβRII interface. The seven ordered residues (Asn19–Pro25) of the N-terminal extension of TβRII (green) are shown as sticks. TβRI (yellow-gold) is depicted as sticks and as surface. In total, vert, similar 916 Å^2 of TβRI surface is buried upon binding by TβRII.
Figure 5.
Figure 5. N-Terminal Tether of TβRII Recruits TβRI into Ternary Complex
(A) Sequence of N-terminal extension of TβRII. The N-terminal tether (underlined, light green) extends out from the receptor scaffold (dark green) from Pro25 to Asn19. The first 18 residues appear to be unstructured. Numbering (based on the mature N terminus, not the initiator methionine of the signal peptide) refers to the termini of the receptor constructs below.
(B) Native gel analyses of TβRI recruitment by binary complexes of TGFβ3 and N-terminally truncated TβRII variants. BC and TC indicate positions of binary and ternary complexes, respectively.
(C) Native gel analyses of TβRI recruitment by binary complexes of TGF-β3 and Δ20 TβRII point variants.
(D) SPR analyses of TβRI recruitment by binary complexes of Δ20 TβRII point variants and fully truncated (Δ25) TβRII.
 
  The above figures are reprinted by permission from Cell Press: Mol Cell (2008, 29, 157-168) copyright 2008.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20870411 J.J.Worthington, J.E.Klementowicz, and M.A.Travis (2011).
TGFβ: a sleeping giant awoken by integrins.
  Trends Biochem Sci, 36, 47-54.  
21423151 T.Huang, L.David, V.Mendoza, Y.Yang, M.Villarreal, K.De, L.Sun, X.Fang, F.López-Casillas, J.L.Wrana, and A.P.Hinck (2011).
TGF-β signalling is mediated by two autonomously functioning TβRI:TβRII pairs.
  EMBO J, 30, 1263-1276.  
21186301 Y.Glinka, S.Stoilova, N.Mohammed, and G.J.Prud'homme (2011).
Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta.
  Carcinogenesis, 32, 613-621.  
20870325 C.L.Shovlin (2010).
Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment.
  Blood Rev, 24, 203-219.  
20890540 L.Li, B.P.Orner, T.Huang, A.P.Hinck, and L.L.Kiessling (2010).
Peptide ligands that use a novel binding site to target both TGF-β receptors.
  Mol Biosyst, 6, 2392-2402.  
20101206 N.Garamszegi, S.P.Garamszegi, P.Samavarchi-Tehrani, E.Walford, M.M.Schneiderbauer, J.L.Wrana, and S.P.Scully (2010).
Extracellular matrix-induced transforming growth factor-beta receptor signaling dynamics.
  Oncogene, 29, 2368-2380.  
20017116 R.L.Rich, and D.G.Myszka (2010).
Grading the commercial optical biosensor literature-Class of 2008: 'The Mighty Binders'.
  J Mol Recognit, 23, 1.  
20493522 U.Ripamonti, R.M.Klar, L.F.Renton, and C.Ferretti (2010).
Synergistic induction of bone formation by hOP-1, hTGF-beta3 and inhibition by zoledronate in macroporous coral-derived hydroxyapatites.
  Biomaterials, 31, 6400-6410.  
20625381 W.Zhang, J.Yuan, Y.Yang, L.Xu, Q.Wang, W.Zuo, X.Fang, and Y.G.Chen (2010).
Monomeric type I and type III transforming growth factor-β receptors and their dimerization revealed by single-molecule imaging.
  Cell Res, 20, 1216-1223.  
19079339 A.A.Mourskaia, Z.Dong, S.Ng, M.Banville, J.C.Zwaagstra, M.D.O'Connor-McCourt, and P.M.Siegel (2009).
Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
  Oncogene, 28, 1005-1015.  
19787707 A.Chaudhury, and P.H.Howe (2009).
The tale of transforming growth factor-beta (TGFbeta) signaling: a soigné enigma.
  IUBMB Life, 61, 929-939.  
19229295 A.Kotzsch, J.Nickel, A.Seher, W.Sebald, and T.D.Müller (2009).
Crystal structure analysis reveals a spring-loaded latch as molecular mechanism for GDF-5-type I receptor specificity.
  EMBO J, 28, 937-947.
PDB code: 3evs
19845874 D.Chen, Q.Lin, N.Box, D.Roop, S.Ishii, K.Matsuzaki, T.Fan, T.J.Hornyak, J.A.Reed, E.Stavnezer, N.A.Timchenko, and E.E.Medrano (2009).
SKI knockdown inhibits human melanoma tumor growth in vivo.
  Pigment Cell Melanoma Res, 22, 761-772.  
19096363 I.M.Liu, S.H.Schilling, K.A.Knouse, L.Choy, R.Derynck, and X.F.Wang (2009).
TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch.
  EMBO J, 28, 88-98.  
19161338 J.Baardsnes, C.S.Hinck, A.P.Hinck, and M.D.O'Connor-McCourt (2009).
TbetaR-II discriminates the high- and low-affinity TGF-beta isoforms via two hydrogen-bonded ion pairs.
  Biochemistry, 48, 2146-2155.  
19644449 J.N.Cash, C.A.Rejon, A.C.McPherron, D.J.Bernard, and T.B.Thompson (2009).
The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding.
  EMBO J, 28, 2662-2676.
PDB code: 3hh2
19926516 J.Nickel, W.Sebald, J.C.Groppe, and T.D.Mueller (2009).
Intricacies of BMP receptor assembly.
  Cytokine Growth Factor Rev, 20, 367-377.  
19502096 L.David, J.J.Feige, and S.Bailly (2009).
Emerging role of bone morphogenetic proteins in angiogenesis.
  Cytokine Growth Factor Rev, 20, 203-212.  
19147499 M.M.Rechtman, A.Nakaryakov, K.E.Shapira, M.Ehrlich, and Y.I.Henis (2009).
Different Domains Regulate Homomeric and Heteromeric Complex Formation among Type I and Type II Transforming Growth Factor-{beta} Receptors.
  J Biol Chem, 284, 7843-7852.  
  19701502 M.Tian, and W.P.Schiemann (2009).
Preclinical efficacy of cystatin C to target the oncogenic activity of transforming growth factor Beta in breast cancer.
  Transl Oncol, 2, 174-183.  
19539633 S.Wang, and R.Hirschberg (2009).
Diabetes-relevant regulation of cultured blood outgrowth endothelial cells.
  Microvasc Res, 78, 174-179.  
18794361 A.C.Daly, R.A.Randall, and C.S.Hill (2008).
Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth.
  Mol Cell Biol, 28, 6889-6902.  
18758450 A.Sorrentino, N.Thakur, S.Grimsby, A.Marcusson, V.von Bulow, N.Schuster, S.Zhang, C.H.Heldin, and M.Landström (2008).
The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.
  Nat Cell Biol, 10, 1199-1207.  
19073914 C.Grütter, T.Wilkinson, R.Turner, S.Podichetty, D.Finch, M.McCourt, S.Loning, L.Jermutus, and M.G.Grütter (2008).
A cytokine-neutralizing antibody as a structural mimetic of 2 receptor interactions.
  Proc Natl Acad Sci U S A, 105, 20251-20256.
PDB codes: 3eo0 3eo1
18706811 D.C.Clarke, and X.Liu (2008).
Decoding the quantitative nature of TGF-beta/Smad signaling.
  Trends Cell Biol, 18, 430-442.  
18243107 J.Massagué (2008).
A very private TGF-beta receptor embrace.
  Mol Cell, 29, 149-150.  
18768470 R.Stamler, H.T.Keutmann, Y.Sidis, C.Kattamuri, A.Schneyer, and T.B.Thompson (2008).
The Structure of FSTL3{middle dot}Activin A Complex: DIFFERENTIAL BINDING OF N-TERMINAL DOMAINS INFLUENCES FOLLISTATIN-TYPE ANTAGONIST SPECIFICITY.
  J Biol Chem, 283, 32831-32838.
PDB code: 3b4v
18436584 Y.Glinka, and G.J.Prud'homme (2008).
Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity.
  J Leukoc Biol, 84, 302-310.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.